Preeclampsia Prevention Protocol

Pregnancy & Maternal HealthStrong Evidence

supplements

Primary

Supporting

Grade A

110

Studies

Primary Stack

Core supplements with strongest evidence

CalciumA

1000-2000mg daily (starting before 20 weeks)

High-dose calcium significantly reduces preeclampsia risk, especially in women with low dietary calcium intake

↑Pre-Eclampsia Risk

25 studies15,000 participants

Supporting Studies (2)

PMID: 24696187 - Calcium supplementation for prevention of preeclampsia: Cochrane review (2014)PMID: 28266644 - WHO guideline on calcium for preeclampsia prevention (2017)

Low-Dose AspirinA

81-150mg daily at bedtime (starting at 12-16 weeks)

Reduces preeclampsia risk by 17% when started before 16 weeks in high-risk women; affects prostaglandin balance

40 studies30,000 participants

Supporting Studies (2)

PMID: 28864169 - Low-dose aspirin for preeclampsia prevention: meta-analysis (2017)PMID: 30089514 - USPSTF aspirin recommendation for preeclampsia (2018)

Supporting Stack

Additional supplements for enhanced results

Vitamin DB

1000-4000 IU daily (based on blood levels)

Deficiency associated with increased preeclampsia risk; supplementation may reduce risk

↑Pre-Eclampsia Risk↑Preterm Birth Risk

15 studies5,000 participants

Supporting Studies (1)

PMID: 28248935 - Vitamin D and preeclampsia: systematic review and meta-analysis (2017)

Omega-3 Fatty AcidsB

1-2g EPA+DHA daily

May improve endothelial function and reduce inflammation; modest evidence for preeclampsia prevention

↓Infant Birth Weight↑Pre-Eclampsia Risk

12 studies3,000 participants

Supporting Studies (1)

PMID: 29560778 - Omega-3 in pregnancy: Cochrane review (2018)

L-ArginineC

3-6g daily

Precursor to nitric oxide; may improve blood vessel function and reduce blood pressure

8 studies500 participants

Supporting Studies (1)

PMID: 25556671 - L-arginine for preeclampsia prevention: systematic review (2015)

Folic AcidC

800-5000mcg daily

Reduces homocysteine; may support endothelial function; higher doses studied for preeclampsia prevention

10 studies2,000 participants

Supporting Studies (1)

PMID: 25687725 - High-dose folic acid for preeclampsia prevention: systematic review (2015)

How This Protocol Works

Simple Explanation

Preeclampsia is a serious pregnancy complication characterized by high blood pressure and protein in the urine, typically developing after 20 weeks of pregnancy. It can progress to eclampsia (seizures) or HELLP syndrome and is a leading cause of maternal and fetal morbidity and mortality. Prevention in high-risk women is a major focus of prenatal care.

CRITICAL: Preeclampsia is a medical emergency. This protocol is for PREVENTION in high-risk women, not treatment. If you develop symptoms (severe headache, visual changes, upper abdominal pain, sudden swelling), seek immediate medical care.

•Calcium supplementation is one of the most effective interventions for preventing preeclampsia. The WHO recommends 1.5-2g daily for pregnant women in populations with low calcium intake. A large Cochrane review found calcium reduces preeclampsia risk by about 55% and is most effective in women with low baseline calcium intake. Start early in pregnancy.

•Low-Dose Aspirin is recommended by ACOG and USPSTF for women at high risk of preeclampsia. When started at 12-16 weeks gestation and taken at bedtime, it reduces preeclampsia risk by about 17% and reduces severe preeclampsia and preterm birth. High-risk factors include previous preeclampsia, chronic hypertension, diabetes, kidney disease, or multiple gestation.

•Vitamin D deficiency is strongly associated with increased preeclampsia risk. Supplementation may help reduce risk, though evidence is still building. Given that vitamin D deficiency is common and supplementation is safe, correcting deficiency is prudent.

•Omega-3 Fatty Acids may help by reducing inflammation and improving blood vessel function. While evidence for preeclampsia prevention specifically is modest, omega-3s have other pregnancy benefits and are generally recommended.

•L-Arginine is a precursor to nitric oxide, which relaxes blood vessels. Some studies suggest it may help prevent preeclampsia by improving blood flow to the placenta, though evidence is limited and it's not a standard recommendation.

•Folic Acid at higher doses may help by reducing homocysteine levels and supporting endothelial function. While standard doses (400-800mcg) are recommended for all pregnancies, higher doses are being studied for preeclampsia prevention.

Who is high-risk: Previous preeclampsia, chronic hypertension, pregestational diabetes, kidney disease, autoimmune disease (lupus, antiphospholipid syndrome), multiple gestation (twins/triplets), first pregnancy, obesity, age >35.

Clinical Perspective

Preeclampsia is a multisystem disorder characterized by new-onset hypertension (≥140/90 mmHg) and proteinuria (≥300mg/24h) or end-organ dysfunction after 20 weeks gestation. Pathophysiology involves abnormal placentation, endothelial dysfunction, oxidative stress, and imbalanced angiogenic factors (sFlt-1/PlGF). Complications include eclampsia, HELLP syndrome, stroke, renal failure, and placental abruption. Prevention in high-risk women is guideline-recommended.

CRITICAL: Preeclampsia requires medical management. Prevention strategies are for identified high-risk women. Treatment is delivery when appropriate plus magnesium sulfate for seizure prophylaxis and antihypertensives as needed.

•Calcium (A-grade): Mechanism may involve reduced PTH, improved endothelial function, and vascular smooth muscle effects. Cochrane review (13 trials, 15,000+ women): high-dose calcium (≥1g/day) reduced preeclampsia risk by 55% (RR 0.45), effect strongest in high-risk women and those with low baseline calcium (PMID: 24696187). WHO recommends 1.5-2g/day in low-calcium populations (PMID: 28266644). Start before 20 weeks; take in divided doses.

•Low-Dose Aspirin (A-grade): Inhibits platelet thromboxane A2 synthesis, restoring prostacyclin/thromboxane balance. Meta-analysis: aspirin started ≤16 weeks reduces preeclampsia (RR 0.83), severe preeclampsia (RR 0.58), and preterm birth (PMID: 28864169). USPSTF recommends 81mg daily for high-risk women starting at 12-16 weeks (PMID: 30089514). ACOG recommends 81-150mg at bedtime. High-risk criteria defined by professional guidelines.

•Vitamin D (B-grade): VDR in placenta; vitamin D regulates angiogenic factors, immune function, and blood pressure. Meta-analysis: vitamin D deficiency associated with 2-fold increased preeclampsia risk; supplementation may reduce risk (PMID: 28248935). Target 25(OH)D ≥40 ng/mL. 1000-4000 IU daily; higher doses if deficient.

•Omega-3 Fatty Acids (B-grade): EPA/DHA reduce inflammation, improve endothelial function. Cochrane review: omega-3 reduces preterm birth; modest/inconsistent evidence for preeclampsia specifically (PMID: 29560778). Other pregnancy benefits support use. 1-2g EPA+DHA daily.

•L-Arginine (C-grade): Precursor for nitric oxide synthesis via eNOS. NO deficiency implicated in preeclampsia. Systematic review: limited evidence suggests potential benefit; more research needed (PMID: 25556671). Not standard recommendation. 3-6g daily if used.

•Folic Acid (C-grade): Reduces homocysteine (elevated in preeclampsia), may support endothelial function. Systematic review: some evidence for higher-dose folic acid (>800mcg) reducing preeclampsia, though data inconsistent (PMID: 25687725). Standard recommendation (400-800mcg) already universal; higher doses under investigation.

Biomarker targets: Blood pressure monitoring, urine protein, sFlt-1/PlGF ratio (emerging biomarker), 25(OH)D, dietary calcium assessment, symptoms (headache, visual changes, RUQ pain, edema).

Protocol notes: ACOG high-risk criteria for aspirin: prior preeclampsia, multifetal gestation, chronic hypertension, type 1 or 2 diabetes, kidney disease, autoimmune disease. Moderate risk with ≥2 factors: first pregnancy, age ≥35, BMI >30, family history preeclampsia, previous adverse outcome. Regular prenatal care with BP monitoring essential. Home BP monitoring may be useful in high-risk. Address modifiable risk factors: optimize weight before pregnancy, control chronic hypertension and diabetes. Delivery timing based on severity and gestational age. Magnesium sulfate for seizure prophylaxis. Postpartum monitoring critical (preeclampsia can develop postpartum). Long-term: increased cardiovascular disease risk—lifestyle modification and monitoring.

View All Protocols